1,172 research outputs found
Therapeutic Approaches to Vascular Protection in Ischemic Stroke
Reperfusion with recombinant tissue plasminogen activator (tPA) sometimes causes catastrophic hemorrhagic transformation (HT) in the ischemic brain. Consequently, the application of tPA has been strictly limited. Recent studies have indicated that matrix metalloproteinases (MMPs), especially MMP-9, play a critical role in blood brain barrier (BBB) disruption in the ischemic brain, leading to brain edema and HT. In the ischemic brain, free radicals and exogenous tPA itself can trigger MMP-9 activation through several signaling pathways containing LDL receptor-related protein (LRP) and proteinase-activated receptor 1 (PAR1). Therapeutic targeting of free radicals and MMP-9/t-PA related signaling pathways might be promising approaches to minimizing catastrophic HT in acute stroke patients. We provide an overview of the available scientific reports to improve our understanding of the mechanisms leading to HT, and highlight recent progress in the development of new therapeutic strategies for preventing HT in the post-stroke brain
The Wiedemann Effect of the Magnetostriction Alloy "Alfer" at High Temperatures
The Wiedemann effect of "Alfer" (12.91 per cent Al-Fe alloy) was measured with the annealed specimen at high temperatures. As the temperature rises, the effect gradually decreases at the constant current through the specimen, and also the higher the temperature is, the weaker the field is for the maximum effect. When the current through the specimen as well as the longitudinal field is constant, the effect gradually decreases with the rise of temperature, and bcecomes extremely small at the magnetic transformation point of the Fe_3Al superlattice, and vanishes at the magnetic transformation point of α phase. The effect of Ni and Fe was measured to compare with that of Alfer. The temperature dependence of the effect of Ni is similar to that of Alfer, but that of Fe is different from both, that is, it gradually increases as the temperature rises, and after reaching a maximum at about 600℃, rapidly decreases, becoming zero at the magnetic transformation point
Evaluating Flood Discharge and Bed Variation In The OTA River Floodway
Source: ICHE Conference Archive - https://mdi-de.baw.de/icheArchiv
Effect of edaravone on pregnant mice and their developing fetuses subjected to placental ischemia
Growing evidence indicates that reduced uterine perfusion pressure (RUPP) triggers the cascade of events leading to preeclampsia. Edaravone is a powerful free radical scavenger used for the treatment of ischemia/reperfusion diseases due to its anti-oxidative stress and anti-inflammatory properties. Here we investigate the effect of edaravone (3 mg/kg) on different maternal and fetal outcomes of RUPP-induced placental ischemia mice model. RUPP surgery was performed on gestation day (GD) 13 followed by edaravone injection from GD14 to GD18, sacrifice day. The results showed that edaravone injection significantly decreased the maternal blood pressure (113.2 +/- 2.3 mmHg) compared with RUPP group (131.5 +/- 1.9 mmHg). Edaravone increased fetal survival rate (75.4%) compared with RUPP group (54.4%), increased fetal length, weights, and feto-placental ratio (7.2 and 5.7 for RUPP and RUPP-Edaravone groups, respectively) compared with RUPP group. In addition, RUPP resulted in many fetal morphological abnormalities as well as severe delayed ossification, however edaravone decreased the morphological abnormalities and increased the ossification of the fetal endoskeleton. Edaravone improved the histopathological structure of the maternal kidney and heart as well as decreased the elevated blood urea and creatinine levels (31.5 +/- 0.15 mg/dl (RUPP), 25.6 +/- 0.1 mg/dl (RUPP+edaravone) for urea and 5.4 +/- 0.1 mg/dl (RUPP), 3.5 +/- 0.1 mg/dl (RUPP+edaravone) for creatinine) and decreased cleaved caspase-3 expression in the maternal kidney. In conclusion, this study demonstrated that our RUPP mice model recapitulated preeclampsia symptoms and edaravone injection ameliorated most of these abnormalities suggesting its effectiveness and potential application in preeclampsia treatment regimes
- …